Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Wissenschaftlicher Artikel
Authors
Zucca, E.
Arcaini, L.
Buske, Christian
Johnson, P. W.
Ponzoni, M.
Institutions
UKU. Comprehensive Cancer Center Ulm (CCCU)Published in
Annals of oncology ; 31 (2020), 1. - S. 17-29. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1016/j.annonc.2019.10.010Keywords
marginal zone B-cell lymphoma (MZL); extranodal marginal zone lymphoma (EMZL); splenic marginal zone lymphoma (SMZL); nodal marginal zone lymphoma (NMZL); mucosa-associated lymphoid tissue (MALT); clinical practice guidelines; B-CELL LYMPHOMA; GASTRIC MALT LYMPHOMA; HELICOBACTER-PYLORI ERADICATION; RITUXIMAB MONOTHERAPY; TISSUE LYMPHOMA; RISK STRATIFICATION; RADIATION-THERAPY; MULTICENTER; PHASE-2; RADIOTHERAPYDewey Decimal Group
DDC 610 / Medicine & healthMetadata
Show full item recordThis could also interest you:
-
Rituximab biosimilars for lymphoma in Europe
Jurczak, Wojciech; Danecka, Monika Dlugosz; Buske, Christian (2019)Wissenschaftlicher Artikel
-
Indolent lymphoma. Therapy strategies
Viardot, Andreas; Herfarth, Klaus; Dreyling, Martin (2015)Wissenschaftlicher Artikel
-
Chromosomal aberrations in lymphomas of the gastrointestinal tract
Barth, TFE et al. (1999)Wissenschaftlicher Artikel